Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Robert M. Staruch, Kullervo Hynynen & Rajiv Chopra. (2015) Hyperthermia-mediated doxorubicin release from thermosensitive liposomes using MR-HIFU: Therapeutic effect in rabbit Vx2 tumours. International Journal of Hyperthermia 31:2, pages 118-133.
Read now
Read now
Pete Anderson, Patricia Wells, Theresa Lazarte, Laura Gore, Laura Salvador & Maritza Salazar-Abshire. (2013) Outpatient chemotherapy, family-centered care, electronic information, and education in adolescents and young adults with osteosarcoma. Clinical Oncology in Adolescents and Young Adults 3, pages 1-11.
Read now
Read now
Articles from other publishers (29)
Thomas S Przybycien. (2021) Dexrazoxane decreases the cardiotoxic effects of doxorubicin in osteosarcoma patients without increasing mortality from secondary malignant neoplasms. Clinical Research In Practice: The Journal of Team Hippocrates 7:1.
Crossref
Crossref
Stefan Bielack, Matthew G. Cable, Richard Gorlick, Stefanie Hecker-Nolting, Leo Kager, Neyssa Marina, R. Lor Randall & Jeremy Whelan. 2021. Sarcomas of Bone and Soft Tissues in Children and Adolescents. Sarcomas of Bone and Soft Tissues in Children and Adolescents
91
109
.
Sarah Dewilde, Kevin Carroll, Emilia Nivelle & James Sawyer. (2020) Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective. Cost Effectiveness and Resource Allocation 18:1.
Crossref
Crossref
Thomas D. Ryan, Rajaram Nagarajan & Justin Godown. (2019) Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients. Current Treatment Options in Oncology 20:7.
Crossref
Crossref
Kelly Liesse, Jamie Harris, Megan Chan, Mary L. Schmidt & Bill Chiu. (2018) Dexrazoxane Significantly Reduces Anthracycline-induced Cardiotoxicity in Pediatric Solid Tumor Patients: A Systematic Review. Journal of Pediatric Hematology/Oncology 40:6, pages 417-425.
Crossref
Crossref
Francois Dionne, Folefac Aminkeng, Amit P. Bhavsar, Gabriella Groeneweg, Anne Smith, Henk Visscher, Shahrad Rod Rassekh, Colin Ross & Bruce Carleton. (2018) An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines. Pediatric Blood & Cancer 65:3, pages e26887.
Crossref
Crossref
Jamie Golden, Aaron R. Jensen, David W. Bliss & Jeffrey S. Upperman. 2018. Surgical Critical Care Therapy. Surgical Critical Care Therapy
573
590
.
G. Biasillo, C.M. Cipolla & D. Cardinale. 2017. Cardio-Oncology. Cardio-Oncology
107
122
.
Dennis A. Priebat. 2017. Sarcoma. Sarcoma
223
255
.
Angela Esposito, Carmen Criscitiello, Douglas B. Sawyer & Giuseppe Curigliano. 2017. Cardio-Oncology. Cardio-Oncology
241
252
.
Jose Luis Zamorano, Patrizio Lancellotti, Daniel Rodriguez Muñoz, Victor Aboyans, Riccardo Asteggiano, Maurizio Galderisi, Gilbert Habib, Daniel J. Lenihan, Gregory Y. H. Lip, Alexander R. Lyon, Teresa Lopez Fernandez, Dania Mohty, Massimo F. Piepoli, Juan Tamargo, Adam Torbicki, Thomas M. Suter, Jose Luis Zamorano, Victor Aboyans, Stephan Achenbach, Stefan Agewall, Lina Badimon, Gonzalo Barón‐Esquivias, Helmut Baumgartner, Jeroen J. Bax, Héctor Bueno, Scipione Carerj, Veronica Dean, Çetin Erol, Donna Fitzsimons, Oliver Gaemperli, Paulus Kirchhof, Philippe Kolh, Patrizio Lancellotti, Gregory Y. H. Lip, Petros Nihoyannopoulos, Massimo F. Piepoli, Piotr Ponikowski, Marco Roffi, Adam Torbicki, António Vaz Carneiro, Stephan Windecker, Stephan Achenbach, Giorgio Minotti, Stefan Agewall, Lina Badimon, Héctor Bueno, Daniela Cardinale, Scipione Carerj, Giuseppe Curigliano, Evandro de Azambuja, Susan Dent, Cetin Erol, Michael S. Ewer, Dimitrios Farmakis, Rainer Fietkau, Donna Fitzsimons, Oliver Gaemperli, Paulus Kirchhof, Philippe Kohl, Paul McGale, Piotr Ponikowski, Juergen Ringwald, Marco Roffi, Jeanette Schulz‐Menger, Justin Stebbing, Rudolf K. Steiner, Sebastian Szmit, Antonio Vaz Carneiro & Stephan Windecker. (2016) 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. European Journal of Heart Failure 19:1, pages 9-42.
Crossref
Crossref
Jose Luis Zamorano, Patrizio Lancellotti, Daniel Rodriguez Muñoz, Victor Aboyans, Riccardo Asteggiano, Maurizio Galderisi, Gilbert Habib, Daniel J. Lenihan, Gregory Y. H. Lip, Alexander R. Lyon, Teresa Lopez Fernandez, Dania Mohty, Massimo F. Piepoli, Juan Tamargo, Adam Torbicki & Thomas M. Suter. (2016) 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. European Heart Journal 37:36, pages 2768-2801.
Crossref
Crossref
Furqan Shaikh, L. Lee Dupuis, Sarah Alexander, Abha Gupta, Luc Mertens & Paul C. Nathan. (2015) Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis. Journal of the National Cancer Institute 108:4, pages djv357.
Crossref
Crossref
Sumati Gupta, Launce Gouw, Jennifer Wright, Sant Chawla, Debbie Pitt, Mark Wade, Ken Boucher & Sunil Sharma. (2016) Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation. Investigational New Drugs 34:2, pages 243-252.
Crossref
Crossref
Angela Esposito, Lucia Gelao, Carmen Criscitiello & Giuseppe Curigliano. 2015. Heart and Toxins. Heart and Toxins
341
361
.
Michela Salvatici, Daniela Cardinale, Alessandro Colombo & Maria Teresa Sandri. 2015. Biomarkers in Cancer. Biomarkers in Cancer
73
105
.
Shashi Raj, Vivian I. Franco & Steven E. Lipshultz. (2014) Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment. Current Treatment Options in Cardiovascular Medicine 16:6.
Crossref
Crossref
Alessandro Colombo, Maria T. Sandri, Michela Salvatici, Carlo M. Cipolla & Daniela Cardinale. (2014) Cardiac Complications of Chemotherapy: Role of Biomarkers. Current Treatment Options in Cardiovascular Medicine 16:6.
Crossref
Crossref
Yan-Ping Zhang, Alan L Myers, Van A Trinh, Jitesh D Kawedia, Mark A Kramer, Robert S Benjamin & Hai T Tran. (2013) Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions. Journal of Oncology Pharmacy Practice 20:1, pages 58-64.
Crossref
Crossref
P.M. Anderson, P. Meyers, E. Kleinerman, K. Venkatakrishnan, D.P. Hughes, C. Herzog, W. Huh, R. Sutphin, Y.M. Vyas, V. Shen, A. Warwick, N. Yeager, C. Oliva, B. Wang, Y. Liu & A. Chou. (2013) Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments. Pediatric Blood & Cancer 61:2, pages 238-244.
Crossref
Crossref
Arthur J. Weiss, Irwin L. Stoloff, Antonio C. Simoes & Richard D. Lackman. (2014) The Relation between the Initial Type of Schedule Used to Administer Doxorubicin and Long-Term Doxorubicin Cardiotoxicity. Journal of Cancer Therapy 05:12, pages 1145-1152.
Crossref
Crossref
Michela Salvatici, Daniela Cardinale, Alessandro Colombo & Maria Teresa Sandri. 2014. Biomarkers in Cancer. Biomarkers in Cancer
1
26
.
Ming-cheng Lin & Mei-chin Yin. (2013) Preventive Effects of Ellagic Acid Against Doxorubicin-Induced Cardio-Toxicity in Mice. Cardiovascular Toxicology 13:3, pages 185-193.
Crossref
Crossref
Alessandro Colombo, Carlo A. Meroni, Carlo M. Cipolla & Daniela Cardinale. (2013) Managing Cardiotoxicity of Chemotherapy. Current Treatment Options in Cardiovascular Medicine 15:4, pages 410-424.
Crossref
Crossref
Daniela Cardinale, Giulia Bacchiani, Marta Beggiato, Alessandro Colombo & Carlo M. Cipolla. (2013) Strategies to Prevent and Treat Cardiovascular Risk in Cancer Patients. Seminars in Oncology 40:2, pages 186-198.
Crossref
Crossref
Steven E. LipshultzTracie L. MillerStuart R. LipsitzDonna S. NeubergSuzanne E. DahlbergSteven D. Colan, Lewis B. SilvermanJacqueline M. HenkelVivian I. FrancoLaura L. CushmanBarbara L. AsselinLuis A. ClavellUma AthaleBruno MichonCaroline LaverdièreMarshall A. SchorinEric Larsen, Naheed Usmani & Stephen E. Sallan. (2012) Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes. Pediatrics 130:6, pages 1003-1011.
Crossref
Crossref
G. Curigliano, D. Cardinale, T. Suter, G. Plataniotis, E. de Azambuja, M.T. Sandri, C. Criscitiello, A. Goldhirsch, C. Cipolla & F. Roila. (2012) Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Annals of Oncology 23, pages vii155-vii166.
Crossref
Crossref
Sherif S. Morgan & Lee D. Cranmer. (2011) Systematic Therapy for Unresectable or Metastatic Soft-Tissue Sarcomas: Past, Present, and Future. Current Oncology Reports 13:4, pages 331-349.
Crossref
Crossref
Daniela Cardinale. (2011) Treatment and prevention of cardiotoxicity due to anticancer therapy. Journal of Cardiovascular Echography 21:2, pages 92-100.
Crossref
Crossref